BRCA1/2 testing in hereditary breast and ovarian cancer families III: Risk perception and screening
β Scribed by Aideen McInerney-Leo; Donald Hadley; Ronald G. Kase; Therese R. Giambarresi; Jeffery P. Struewing; Barbara Bowles Biesecker
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 173 KB
- Volume
- 140A
- Category
- Article
- ISSN
- 1552-4825
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We identified 17 BRCA1 mutations in 86 Austrian breast and ovarian cancer families (20%) that were screened for mutations by denaturing high-performance liquid chromatography (DHPLC) and the protein truncation test (PTT). Eleven distinct mutations were detected, 4 of them (962del4, 2795del4, 3135del
## Abstract It remains uncertain whether members of hereditary breast and ovarian cancer (HBOC) families experience psychological distress with genetic testing and whether preβtest counseling can have a moderating effect on client wellβbeing. One purpose of this study was to assess change in psycho
A group of 83 Spanish BC/OC families were analysed for BRCA1 germ-line mutations. Analysis of the entire coding sequence was carried out by SSCP and PTT. We identified 5 frameshift mutations: 185delAG (2 times), 189insTGTC, 1241delAC, and 5537delA and 3 missense mutations in BRCA1: 330A G G, 1240C G